SOUTH SAN FRANCISCO - ALX Oncology Holdings Inc. (NASDAQ:ALXO), a clinical-stage biotechnology company with a market capitalization of approximately $95 million, reported positive outcomes from its ...
Charting, Price Performance, News & Related Contracts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback